Holen Sie sich die Stockscreener-App
437.10
2.19%
9.37
Handel nachbörslich:
438.90
1.80
+0.41%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt MDGL?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$427.73
Offen:
$426.56
24-Stunden-Volumen:
241.53K
Relative Volume:
0.64
Marktkapitalisierung:
$9.71B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-518.67M
KGV:
-17.40
EPS:
-25.12
Netto-Cashflow:
$-438.32M
1W Leistung:
+0.19%
1M Leistung:
+1.13%
6M Leistung:
+35.61%
1J Leistung:
+102.90%
1-Tages-Spanne:
$420.02
$439.45
1-Wochen-Bereich:
$416.29
$445.00
52-Wochen-Spanne:
$200.63
$463.62
Madrigal Pharmaceuticals Inc Stock (MDGL) Company Profile
Firmenname
Madrigal Pharmaceuticals Inc
Sektor
Branche
Telefon
404-380-9263
Adresse
200 BARR HARBOR DRIVE, SUITE 400, WEST CONSHOHOCKEN, PA
Vergleichen Sie MDGL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MDGL
Madrigal Pharmaceuticals Inc
|
437.10 | 9.53B | 0 | -518.67M | -438.32M | -25.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Madrigal Pharmaceuticals Inc Stock (MDGL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-04 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-02-28 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2025-02-27 | Bestätigt | H.C. Wainwright | Buy |
| 2024-06-28 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2024-06-11 | Eingeleitet | Wolfe Research | Outperform |
| 2024-04-22 | Eingeleitet | BofA Securities | Underperform |
| 2024-03-15 | Hochstufung | B. Riley Securities | Sell → Neutral |
| 2024-03-06 | Eingeleitet | Citigroup | Buy |
| 2024-02-26 | Herabstufung | B. Riley Securities | Neutral → Sell |
| 2022-12-20 | Bestätigt | Oppenheimer | Outperform |
| 2022-12-19 | Bestätigt | H.C. Wainwright | Buy |
| 2022-12-19 | Bestätigt | Piper Sandler | Overweight |
| 2022-12-19 | Hochstufung | Raymond James | Underperform → Mkt Perform |
| 2022-07-08 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2021-10-07 | Eingeleitet | Jefferies | Buy |
| 2021-08-06 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2021-05-20 | Fortgesetzt | Goldman | Buy |
| 2020-11-24 | Fortgesetzt | Evercore ISI | Outperform |
| 2020-11-06 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-31 | Eingeleitet | Piper Sandler | Overweight |
| 2020-06-05 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2020-05-05 | Eingeleitet | Chardan Capital Markets | Buy |
| 2020-01-30 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-01-09 | Hochstufung | UBS | Neutral → Buy |
| 2019-11-07 | Bestätigt | H.C. Wainwright | Buy |
| 2019-06-25 | Eingeleitet | Stifel | Hold |
| 2019-06-10 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2019-02-28 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-22 | Eingeleitet | SVB Leerink | Outperform |
| 2019-01-23 | Eingeleitet | UBS | Neutral |
| 2018-12-14 | Eingeleitet | Wolfe Research | Outperform |
| 2018-12-12 | Eingeleitet | B. Riley FBR | Neutral |
| 2018-11-19 | Herabstufung | Raymond James | Mkt Perform → Underperform |
| 2018-11-16 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-09-04 | Eingeleitet | Citigroup | Buy |
| 2018-08-06 | Herabstufung | Goldman | Buy → Neutral |
| 2018-06-28 | Eingeleitet | Raymond James | Mkt Perform |
Alle ansehen
Madrigal Pharmaceuticals Inc Aktie (MDGL) Neueste Nachrichten
Madrigal Pharmaceuticals Inc. recovery potential after sell off2025 Volume Leaders & Community Consensus Trade Signals - newser.com
Applying big data sentiment scoring on Madrigal Pharmaceuticals Inc.Quarterly Portfolio Report & Target Return Focused Picks - newser.com
Published on: 2025-10-14 01:39:18 - newser.com
How to use a screener to detect Madrigal Pharmaceuticals Inc. breakouts2025 Technical Overview & Real-Time Stock Movement Alerts - newser.com
Detecting support and resistance levels for Madrigal Pharmaceuticals Inc.Dip Buying & Intraday High Probability Setup Alerts - newser.com
Using RSI to spot recovery in Madrigal Pharmaceuticals Inc.2025 Market Trends & AI Forecasted Entry and Exit Points - newser.com
Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Potential Upside in the High-Stakes Biotech Arena - DirectorsTalk Interviews
Madrigal Pharmaceuticals Grants Equity Awards to New Employees Under 2025 Inducement Plan - MyChesCo
Sivik Global Healthcare LLC Acquires New Holdings in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Live market analysis of Madrigal Pharmaceuticals Inc.Portfolio Performance Report & Consistent Return Investment Signals - newser.com
Wealth Enhancement Advisory Services LLC Acquires New Shares in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Madrigal Pharmaceuticals (MDGL) Sees Target Price Hike by Oppenheimer | MDGL Stock News - GuruFocus
Madrigal Pharmaceuticals stock price target raised by Oppenheimer to $590 - Investing.com Canada
How to monitor Madrigal Pharmaceuticals Inc. with trend dashboardsGold Moves & Fast Entry Momentum Trade Alerts - newser.com
Is Madrigal Pharmaceuticals Inc. stock bottoming outTrade Analysis Summary & Weekly Stock Breakout Alerts - newser.com
Will earnings trigger a reversal in Madrigal Pharmaceuticals Inc.July 2025 Recap & Expert Approved Momentum Trade Ideas - newser.com
Weiss Ratings Reiterates "Sell (D-)" Rating for Madrigal Pharmaceuticals (NASDAQ:MDGL) - MarketBeat
Madrigal Pharmaceuticals gains amid takeover speculation - MSN
Madrigal Pharmaceuticals Reports Promising Two-Year Results for MASH Therapy - MSN
What analysts say about Madrigal Pharmaceuticals Inc YDO1 stockSwing Trading Watchlist & Never Miss the Next Wealth Opportunity - earlytimes.in
Madrigal Pharmaceuticals Inc. stock daily chart insightsGold Moves & Accurate Intraday Trade Tips - newser.com
Market reaction to Madrigal Pharmaceuticals Inc.’s recent news2025 Fundamental Recap & Weekly Momentum Stock Picks - newser.com
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Knights of Columbus Asset Advisors LLC Increases Stock Position in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
How strong is Madrigal Pharmaceuticals Inc. (YDO1) stock earnings growthTrade Analysis Report & Fast Moving Stock Trade Plans - newser.com
Short interest data insights for Madrigal Pharmaceuticals Inc.Quarterly Profit Summary & AI Enhanced Trading Signals - newser.com
Will Madrigal Pharmaceuticals Inc. (YDO1) stock keep high P E multiplesJuly 2025 Rallies & Long-Term Investment Growth Plans - newser.com
Madrigal Pharmaceuticals (MDGL) Stock Analysis: A Biotech Powerhouse with 10.5% Upside Potential - DirectorsTalk Interviews
Strid Group LLC Buys Shares of 2,500 Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Published on: 2025-10-05 03:01:06 - newser.com
J. Safra Sarasin Holding AG Increases Holdings in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Madrigal Pharmaceuticals Hits New 52-Week High of $463.48 - Markets Mojo
Signal strength of Madrigal Pharmaceuticals Inc. stock in tech scannersJuly 2025 Opening Moves & Low Risk Investment Opportunities - newser.com
Q3 Earnings Estimate for MDGL Issued By B. Riley - Defense World
How to use Fibonacci retracement on Madrigal Pharmaceuticals Inc.Earnings Overview Report & Technical Pattern Based Signals - newser.com
What is B. Riley's Forecast for MDGL Q3 Earnings? - MarketBeat
Madrigal Pharmaceuticals, Inc. $MDGL Holdings Decreased by AMI Asset Management Corp - MarketBeat
Madrigal Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference - MSN
Madrigal Pharmaceuticals Achieves 114.43% Annual Growth, Marking It as a Multibagger Stock - Markets Mojo
Madrigal Pharmaceuticals Hits Day High with 8.43% Surge in Stock Price - Markets Mojo
Madrigal Pharmaceuticals Hits New 52-Week High of $460.00 - Markets Mojo
What drives Madrigal Pharmaceuticals Inc YDO1 stock priceSupport Zone Identification & Low Risk High Yield - earlytimes.in
Can Prince Pipes and Fittings Limited Reach New Highs in YEAR Resistance Levels ReviewedBreakout Stock Watch & Rapid Profit Growth - earlytimes.in
Madrigal Pharmaceuticals (NASDAQ:MDGL) Reaches New 52-Week High on Analyst Upgrade - Defense World
Madrigal Pharmaceuticals (NASDAQ:MDGL) Hits New 52-Week High After Analyst Upgrade - MarketBeat
Madrigal Pharmaceuticals stock hits all-time high at 457.47 USD By Investing.com - Investing.com Australia
Madrigal Pharmaceuticals stock hits all-time high at 457.47 USD - Investing.com India
Finanzdaten der Madrigal Pharmaceuticals Inc-Aktie (MDGL)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):